Efficacy of RTS,S malaria vaccines: Individual-participant pooled analysis of phase 2 data

Efficacy of RTS,S malaria vaccines: Individual-participant pooled analysis of phase 2 data

Zobrazit další vydání (1)

Background: The efficacy of RTS,S/AS01 as a vaccine for malaria is being tested in a phase 3 clinical trial. Early results show significant, albeit partial, protection against clinical malaria and severe malaria. To ascertain variations in vaccine efficacy according to covariates such as transmissio...

Podrobná bibliografie
Hlavní autoři:	Bejon, P, White, M, Olotu, A, Bojang, K, Lusingu, J, Salim, N, Otsyula, N, Agnandji, S, Asante, K, Owusu-Agyei, S, Abdulla, S, Ghani, A
Médium:	Journal article
Vydáno:	2013

Podobné jednotky

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.
Autor: Bejon, P, a další
Vydáno: (2013)

A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
Autor: White, M, a další
Vydáno: (2014)

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.
Autor: Warimwe, G, a další
Vydáno: (2013)

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
Autor: Olotu, A, a další
Vydáno: (2010)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
Autor: Bejon, P, a další
Vydáno: (2009)

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
Autor: Olotu, A, a další
Vydáno: (2013)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
Autor: Olotu, A, a další
Vydáno: (2016)

The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection
Autor: White, M, a další
Vydáno: (2013)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
Autor: Bejon, P, a další
Vydáno: (2008)

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status
Autor: Stephaney Gyaase, a další
Vydáno: (2021-01-01)

Response to "Poor control vaccines in two randomised trials of malaria vaccine?".
Autor: Bejon, P, a další
Vydáno: (2009)

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
Autor: Bejon, P, a další
Vydáno: (2011)

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E
Autor: Ndungu, F, a další
Vydáno: (2012)

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children
Autor: Olotu, A, a další
Vydáno: (2014)

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.
Autor: Vekemans, J, a další
Vydáno: (2011)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
Autor: Olotu, A, a další
Vydáno: (2011)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
Autor: Lusingu, J, a další
Vydáno: (2010)

THE RTS,S MALARIA VACCINE What is the efficacy of the RTS,S malaria vaccine?
Autor: Duncan, C, a další
Vydáno: (2011)

The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection.
Autor: Michael T White, a další
Vydáno: (2013-01-01)

PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDREN
Autor: Bejon, P, a další
Vydáno: (2008)

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
Autor: Agnandji, S, a další
Vydáno: (2012)

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
Autor: Horowitz, A, a další
Vydáno: (2012)

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
Autor: Daniel Ansong, a další
Vydáno: (2011-04-01)

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
Autor: Agnandji, S, a další
Vydáno: (2011)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.
Autor: Lievens, M, a další
Vydáno: (2011)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children
Autor: Ndungu, F, a další
Vydáno: (2019)

Correction: Randomized Controlled Trial of RTS,S/AS02 and RTS,S/AS01 Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children.
Autor: Seth Owusu-Agyei, a další
Vydáno: (2010-01-01)

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
Autor: Carlota Dobaño, a další
Vydáno: (2019-05-01)

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
Autor: Seth Owusu-Agyei, a další
Vydáno: (2009-10-01)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
Autor: Ally Olotu, a další
Vydáno: (2011-01-01)

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.
Autor: Ally Olotu, a další
Vydáno: (2014-01-01)

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
Autor: Otieno, L, a další
Vydáno: (2019)

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
Autor: Guerra Mendoza, Y, a další
Vydáno: (2019)

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care
Autor: Vekemans Johan, a další
Vydáno: (2011-08-01)

RTS,S: the first malaria vaccine
Autor: Fidel Zavala
Vydáno: (2022-01-01)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
Autor: John N Waitumbi, a další
Vydáno: (2009-11-01)

What is the efficacy of the RTS,S malaria vaccine?
Autor: Duncan, C, a další
Vydáno: (2011)

What is the efficacy of the RTS,S malaria vaccine?
Autor: Duncan, C, a další
Vydáno: (2011)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
Autor: John Lusingu, a další
Vydáno: (2010-01-01)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
Autor: John Lusingu, a další
Vydáno: (2010-11-01)